Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Acrivon Therapeutics Q3 Earnings

Acrivon Therapeutics (NASDAQ:ACRV) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Acrivon Therapeutics (NASDAQ:ACRV) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Acrivon Therapeutics beat estimated earnings by 7.04%, reporting an EPS of $-0.66 versus an estimate of $-0.71.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 6.81% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Acrivon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stocks Show Optimism Heading Into Midterms Week As Nasdaq, S&P 500 Futures Rally — Apple, Meta, Palantir In Focus Today

By Shanthi Rexaline
November 7, 6:50 AM
U.S. index futures were all in the green on Monday morning, indicating that Wall Street may start the week on a moderately positive note. Monday’s economic calendar is light and doesn’t boast of any major market-moving data or reports. Traders could show apprehension ahead of the Nov. 8 midterm elections and the consumer price inflation report due on Thursday.

AAPL